Chen Hong, Liu Chengyu, Cheng Cheng, Zheng Ling, Huang Kun
Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.
College of Life Sciences, Wuhan University, Wuhan 430072, China.
Curr Protein Pept Sci. 2018;19(2):179-189. doi: 10.2174/1389203718666170918154728.
Diabetes is a metabolic disorder with multiple complications, including cardiomyopathy, retinopathy, nephropathy and neuropathy. Diabetic complications are the major cause of disability and death in diabetic patients. Apelin, a recently identified adipokine peptide, has been found to play important roles in diabetic complications. Here we summarize the current knowledge on the role of apelin in the pathogenesis of different diabetic complications. We also propose that similar to insulin resistance or leptin resistance, diabetics may also show apelin resistance. Potential clinical application of apelin and its analogue peptides in treating diabetic complications is discussed.
糖尿病是一种伴有多种并发症的代谢紊乱疾病,这些并发症包括心肌病、视网膜病变、肾病和神经病变。糖尿病并发症是糖尿病患者致残和死亡的主要原因。Apelin是一种最近发现的脂肪因子肽,已被发现在糖尿病并发症中起重要作用。在此,我们总结了目前关于Apelin在不同糖尿病并发症发病机制中作用的认识。我们还提出,与胰岛素抵抗或瘦素抵抗类似,糖尿病患者可能也存在Apelin抵抗。文中讨论了Apelin及其类似肽在治疗糖尿病并发症方面的潜在临床应用。